Moving Stocks: Agenus Inc. (NASDAQ:AGEN), Boston Scientific Corporation (NYSE:BSX), Penn West Petroleum Ltd.

Zacks Investment Research upgraded shares of Agenus Inc. (NASDAQ:AGEN) from a hold rating to a buy rating in a research report sent to investors on Monday, MarketBeat Ratings reports. They currently have $3.75 price objective on the stock.

Agenus Inc. (NASDAQ:AGEN) belongs to Healthcare sector. Its weekly performance is -6.31%. On last trading day company shares ended up at $2.82. Agenus Inc. (NASDAQ:AGEN) distance from 50-day simple moving average (SMA50) is -14.67%.

Boston Scientific Corporation (NYSE:BSX) said Tuesday that it has received the approval from the U.S. Food and Drug Administration for its ACUITY X4 Quadripolar Left Ventricular leads, the wires that connect cardiac resynchronization therapy devices to the heart.

Boston Scientific Corporation (NYSE:BSX) shares decreased -0.12% in last trading session and ended the day at $17.24. BSX Gross Margin is 71.40% and its return on assets is -1.40%. Boston Scientific Corporation (NYSE:BSX) quarterly performance is -2.16%.

On 16 February, Penn West Petroleum Ltd. (NYSE:PWE) has reached agreements to settle a bevy of class-action lawsuits stemming from accounting. The settlement in the Canadian and U.S. cases will be fully funded by the company’s insurance, meaning its cash resources and financial position won’t take a hit.

Penn West Petroleum Ltd. (NYSE:PWE) belongs to Basic Materials sector. Its weekly performance is 12.05%. On last trading day company shares ended up at $0.93. Penn West Petroleum Ltd. (NYSE:PWE) distance from 50-day simple moving average (SMA50) is 17.25%.

Halozyme Therapeutics, Inc. (NASDAQ:HALO) will webcast its Quarterly Update Conference Call for the fourth quarter and full year 2015 on Monday, February 29 at 4:30 p.m. ET/1:30 p.m. PT. Dr. Helen Torley, president and chief executive officer, will lead the call. On the same date post-market, Halozyme will release financial results for the fourth quarter and year-ended December 31, 2015.

Halozyme Therapeutics, Inc. (NASDAQ:HALO) shares moved down -5.25% in last trading session and ended the day at $7.76. HALO Gross Margin is 76.10% and its return on assets is -25.50%. Halozyme Therapeutics, Inc. (NASDAQ:HALO) quarterly performance is -54.16%.

NVIDIA Corporation (NASDAQ:NVDA) is pushing the newfangled Vulkan graphics API to the SHIELD console, for better graphics resource management. Android Marshmallow to the NVIDIA SHIELD console means we get all the power efficiency, tweaks, new features, and performance gains that Google pushed to the latest version of Android.

On 23 February, NVIDIA Corporation (NASDAQ:NVDA) shares moved up 0.25% and was closed at $31.60. NVDA EPS growth in last 5 year was 20.20%. NVIDIA Corporation (NASDAQ:NVDA) year to date (YTD) performance is -4.13%.

Leave a Reply

Your email address will not be published. Required fields are marked *